Medication-Assisted Treatment for Opioid-Use Disorder
Date Added:
October 3, 2019
Journal/Publication:
Mayo Clinic Proceedings
Publisher:
Mayo Foundation for Medical Education and Research / Elsevier Inc.
Publication Date:
September 9, 2019
Issue:
10
Volume:
94
Pages:
2072-2086
Type:
Meta-analyses, Reviews, and Guidelines
Format:
Article
DOI (1):
10.1016/j.mayocp.2019.03.029
PMID (1):
31543255
Abstract
The United States is in the midst of a national opioid epidemic. Physicians are encouraged both to prevent and treat opioid-use disorders (OUDs). Although there are 3 Food and Drug Administration-approved medications to treat OUD (methadone, buprenorphine, and naltrexone) and there is ample evidence of their efficacy, they are not used as often as they should. We provide a brief review of the 3 primary medications used in the treatment of OUD. Using data from available medical literature, we synthesize existing knowledge and provide a framework for how to determine the optimal approach for outpatient management of OUD with medication-assisted treatments.
Text Availability
Free full text
RPR Commentary
A nice review of how and when to use the three available medications for treating patients with opioid dependency. James W. Mold, MD, MPH